Each year, approximately 177,000 adults aged 65 and older are hospitalized in the United States due to RSV, and an estimated ...

The Office of the Chief Medical Officer has identified two confirmed cases of whooping cough” and the government said that “while there is no known link between the cases, this potentially indicates ...

ADMA stock rocketed Monday after the Food and Drug Administration approved its new immunoglobulin production process.

Detailed results from the CENTERSTONE trial show treatment with Xofluza reduced the odds of transmission, or spread of the ...

Several measures can be adopted to avoid and combat the flu. However, it is important to note that viruses, like influenza, frequently change its structure to evade the immune system, resulting in new ...

The visiting restrictions are due to return to normal at the ‘majority of inpatient wards’ at QA - but the hospital continues ...

The global at-home testing market is poised for remarkable growth, with sales projected to rise from USD 7,789.1 million in 2025 to USD 11,877.8 million by 2035, according to recent market analysis.

A middle school student north of Dallas has tested positive. Meanwhile, Illinois has confirmed its first case in the state. Plus: A study in mice shows that covid is still contagious a week or more ...

A phase 3 trial involving nearly 25,000 older adults across 17 countries found that a single dose of the RSVPreF3 OA vaccine ...

Vulnerable Australians aged 50-59 will be able to receive a vaccine for respiratory syncytial virus (RSV).

A single-dose of the respiratory syncytial virus (RSV) vaccine in older adults showed waning efficacy across three seasons of ...

A landmark global trial shows that one dose of the RSVPreF3 OA vaccine protects older adults against serious RSV lung disease for three seasons, raising hopes for long-term protection with just a ...